ArticleTrials2019

PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study.

E Gaiffe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.